Israeli researchers at Tel Aviv University have developed a groundbreaking sperm selection method that is revolutionizing fertility treatments, increasing the success rates of in vitro fertilization from 34% to 65%. This innovative technology developed by Natan T. Shaked’s lab allows for the precise selection of the highest-quality sperm cells based on stringent criteria, significantly improving the quality of fertilization and enhancing the chances of a successful pregnancy and birth.
The technology has already seen remarkable success, with 20 successful pregnancies out of 31 embryo transfers, far surpassing the 14 pregnancies seen in the control group. This revolutionary approach, which assesses internal sperm structure, motility, and DNA fragmentation in real time without damaging the cells, sets a new standard for sperm selection in IVF, ensuring that only the best sperm are chosen.
With the technology now being advanced through QART Medical, a startup co-founded by Shaked and Alon Shalev, it is currently undergoing clinical trials in hospitals in Israel and two international institutions in the United States and Japan. The company plans for global expansion, with further advancements towards automated sperm selection on the horizon.
This next-generation approach to fertility treatments not only provides hope to countless couples struggling to conceive but also holds promise for improving the health of babies born through IVF. With early results demonstrating nearly double the success rates of conventional IVF, this technology is paving the way for a new era in fertility medicine. It is not just a product but a means to help individuals achieve their dream of building families.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
